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Current teaching and guidelines suggest that aggressive fluid resuscitation is the best initial approach to the
patient with hemodynamic instability. The source of this wisdom is difficult to discern, however, Early Goal Directed
therapy (EGDT) as championed by Rivers et al. and the Surviving Sepsis Campaign Guidelines appears to have
established this as the irrefutable truth. However, over the last decade it has become clear that aggressive fluid
resuscitation leading to fluid overload is associated with increased morbidity and mortality across a diverse group
of patients, including patients with severe sepsis as well as elective surgical and trauma patients and those with
pancreatitis. Excessive fluid administration results in increased interstitial fluid in vital organs leading to impaired
renal, hepatic and cardiac function. Increased extra-vascular lung water (EVLW) is particularly lethal, leading to iatrogenic
salt water drowning. EGDT and the Surviving Sepsis Campaign Guidelines recommend targeting a central venous
pressure (CVP) > 8 mmHg. A CVP > 8 mmHg has been demonstrated to decrease microcirculatory flow, as well as renal
blood flow and is associated with an increased risk of renal failure and death. Normal saline (0.9% salt solution) as
compared to balanced electrolyte solutions is associated with a greater risk of acute kidney injury and death. This paper
reviews the adverse effects of large volume resuscitation, a high CVP and the excessive use of normal saline.
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portive measures may be harmful and the ‘less is more’
paradigm appears applicable. In these highly vulnerable
patients, more intensive treatments may promote the
chances of unwanted adverse effects and hence, iatro-
genic injury [1]. Traditional teaching suggests that ag-
gressive fluid resuscitation is the best initial approach
for the cardiovascular instability of sepsis. In the Rivers’
Early Goal Directed Therapy (EGDT) study, 4.9 liters of
crystalloid were given in the first 6 hours and 13.4 liters
in the first 72 hours [2]. The Surviving Sepsis Campaign
recommends ‘aggressive fluid resuscitation during the
first 24 hours of management’ [3]. The guidelines for
hemodynamic support of sepsis published by the American
College of Critical Care Medicine state that ‘large fluid
deficits exist in patients with septic shock. Up to 6 to 10 li-
ters of crystalloid solutions may be required for initial re-
suscitation in the first 24 hours’ [4]. Consequently, largeCorrespondence: marikpe@evms.edu
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in any medium, provided the original work is pvolumes of fluid are often infused in the early stages of
sepsis. Traditionally, patients undergoing surgery have
been managed with a liberal fluid strategy in which fluids
are administered to fill the non-existent ‘third space’ [5-7].
For patients with traumatic injuries, high volume fluid re-
suscitation is promoted by the early Advanced Trauma
Life Support (ATLS) strategy [8]. There are, however, no
human data to show that large volume fluid resuscitation
reliably improves organ perfusion [9,10]. This approach is
likely to lead to iatrogenic salt water drowning with the
acute respiratory distress syndrome (ARDS), acute kidney
injury (AKI), myocardial injury, gastrointestinal dysfunc-
tion, poor wound healing with an increased the risk of
death [6,11-21]. Aggressive fluid resuscitation is a well-
known risk factor for secondary intra-abdominal hyper-
tension which in turn is associated with hepatic and
respiratory dysfunction, AKI, multiorgan failure and death
[22-27]. Current guidelines suggest targeting a central
venous pressure (CVP) of 8 to 12 mmHg in patients with
severe sepsis and septic shock [28]. However, a high CVP
increases venous pressure, increases organ interstitialn Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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[29,30]. A CVP > 8 mmHg has been associated with an in-
creased risk of renal failure and death [13,16,31]. Normal
saline (0.9% salt solution) is common resuscitation fluid.
However, as compared to balanced electrolyte solutions
normal saline (NS) is associated with a greater risk of
acute kidney injury and death [32-35]. This paper reviews
the adverse effects of large volume resuscitation, a high
CVP and the excessive use of normal saline.
Review
The dangers of large volume resuscitation
From a pathophysiological point of view, large volume
fluid resuscitation in patients with sepsis is illogical and
may worsen the hemodynamic derangements of sepsis.
Sepsis is primarily a vasoplegic state due to increased
production of nitric oxide, activation of KATP channels
and vasopressin deficiency [36]. Vasoplegic shock, due
to failure of the vascular smooth muscle to constrict,
results in arterial and venodilation [36]. Venodilation in-
creases the unstressed vascular compartment, thus de-
creasing venous return. In patients with septic shock
who are fluid responders, vasodilatation with a fall in
systematic vascular resistance has been observed follow-
ing fluid resuscitation [37,38]. A similar finding has been
noted in an experimental sepsis model [21]. Further-
more, it is important to emphasize that the septic heart
responds poorly to fluid loading. In patients with sepsis,
the Frank-Starling curve is shifted downwards and to the
right, with septic patients showing a diminished re-
sponse to fluid loading. This observation was demon-
strated by Ognibene and colleagues over 25 years ago
[39]. Patients in septic shock had a minimal increase in
left ventricular stroke work index (LVSWI) in response
to volume infusion. This suggests that large volume fluid
resuscitation will cause a small increase in stroke volume
(with further vasodilatation) at the expense of large in-
creases in filling pressures (increase in both the CVP
and left atrial pressures). Furthermore, sepsis is charac-
terized by increased endothelial permeability caused by
shedding of the endothelial glycocalyx and the develop-
ment of gaps between endothelial cells (paracellular leak)
[40,41]. An increase in microcirculatory hydrostatic
pressure following aggressive fluid resuscitation in-
creases fluid extravasation. Increased cardiac filling pres-
sures following aggressive fluid resuscitation increase the
release of natriuretic peptides which act synergistically
with nitric oxide causing cGMP mediated vasodilatation
[36]. In addition, natriuretic peptides cleave membrane-
bound proteoglycans and glycoproteins (most notably
syndecan-1 and hyaluronic acid) off the endothelial gly-
cocalyx [42-44]. This profoundly increases endothelial
permeability. Increased natriuretic peptides inhibit the
lymphatic propulsive motor activity reducing lymphaticdrainage [45-47]. Increased natriuretic peptides follow-
ing aggressive fluid resuscitation therefore acts to seques-
trate fluid into the interstitium. Furthermore, increased
filling pressures and a positive fluid balance increase
extra-vascular lung water (EVLW) [18]. Increased EVLW
impairs gas exchange, reduces lung compliance and in-
creases the work of breathing [18]. Increased EVLW is
regarded as a defining feature of acute lung injury/ARDS
[48,49]. Increased EVLW is a strong independent pre-
dictor of death [12,18,50,51]. Due to the endothelial injury,
capillary leak and increased hydrostatic pressures less than
five percent of infused crystalloid remains intravascular
within three hours after infusion resulting in further in-
creases in EVLW and tissue edema [52]. Tissue edema im-
pairs oxygen and metabolite diffusion, distorts tissue
architecture, impedes capillary blood flow and lymphatic
drainage and disturbs cell-cell interactions; these effects
contribute to progressive organ dysfunction [14]. These
effects are pronounced in encapsulated organs, such as
the liver and kidneys, which lack the capacity to accom-
modate additional volume without an increase in intersti-
tial pressure, resulting in compromised organ blood flow
[14]. This may lead to AKI and hepatic congestion with
cholestasis and impaired hepatic function [14]. Myocardial
edema due to excess fluid administration compounds the
myocardial dysfunction common in critically ill patients
[21]. In a cohort of patients requiring mechanical ventila-
tion, Cordemans and colleagues reported significantly
more respiratory, liver and cardiovascular organ-failure
free days in patients’ with a conservative fluid strategy and
those whose EVLW fell by more than 2 ml/kg during their
ICU stay [18]. Bowel edema results in malabsorption, ileus
and bacterial translocation. In patients with pneumonia,
large volume fluid resuscitation may result in severe
ARDS (see Figure 1). The chest radiograph series pre-
sented in Figure 1 represents a typical case of fatal iatro-
genic salt water drowning. This patient was resuscitated
according to the EGDT and the Surviving Sepsis Cam-
paign bundles, in which fluids are administered until the
CVP > 12 mmHg [2,28].
The harmful effects of aggressive fluid resuscitation on
the outcome of sepsis are supported by experimental
studies as well as data accumulated from clinical trials
[15,20,21,31,51,53-58]. Multiple clinical studies have
demonstrated an independent association between an in-
creasingly positive fluid balance and increased mortality
in patient with sepsis [15,18,31,51,53-58]. In a secondary
analysis of the Vasopressin in Septic Shock Trial
(VASST), Boyd and colleagues demonstrated that a
greater positive fluid balance at both 12 hours and 4
days were independent predictors of death [31]. Further-
more, a number of studies have demonstrated that a
positive fluid balance was associated with an increased
risk for AKI [15]. Bouchard et al. demonstrated that in
Figure 1 Fourty-four-year old male with Pneumococcal pneumonia. (a) Initial chest radiograph (CXR) in emergency department. (b) CXR
four hours later after four liters of crystalloid (patient now intubated). (c) CXR 12 hours after admission, after 9 liters of crystalloid, central venous
pressure (CVP) = 10 mmHg. Patient died six hours later of refractory hypoxemia.
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sociated with mortality [58]. In the Fluid and Catheter
Treatment Trial (FACTT), the conservative fluid strat-
egy was associated with a trend towards a reduced re-
quirement for renal replacement therapy [59]. The most
compelling data that fluid loading in sepsis is harmful
come from The Fluid Expansion as Supportive Therapy
(FEAST) study performed in 3,141 sub-Saharan children
with severe sepsis [60]. In this randomized study, aggres-
sive fluid loading was associated with a significantly in-
creased risk of death. Furthermore, there was no
subgroup of patients that benefited from aggressive fluid
resuscitation [61].
Emerging data suggest that less than 50% of septic pa-
tients who present to the emergency department (and
are fluid naive) will be fluid responsive [62]. In some pa-
tients, hypotension and tachycardia do resolve with lim-
ited fluid resuscitation. However, fluids alone will not
reverse the hemodynamic instability of patients with
more severe sepsis; in these patients’ fluids alone are
likely to exacerbate the vasodilatory shock and increase
the capillary leak, tissue edema and organ dysfunction
[21]. In the Australasian Resuscitation of Sepsis Evalu-
ation (ARISE) study which used the same entry criteria
as the EGDT study, 2.2 ± 1.9 liters of fluid were given in
the first 6 hours [63]. This compares to 4.9 liters in the
intervention arm of the EGDT study [2]. The hospital
mortality was 23% in the ARISE study compared to 30%
in the intervention arm of the EGDT study. This differ-
ence in the prescription of fluid is likely due to variabil-
ity in the management style of severe sepsis between
countries. In a survey conducted by Reade et al., intensi-
vists from Australia tended to give less fluid thanTable 1 Contrasting use of fluids and vasopressors (and mort
the Rivers’ and ProCESS studies




Rivers’ EGDT 4,981 8,625
ProCESS EGDT 2,805 4,428Americans with only 15% of Australians targeting a CVP
of 8 to 12 mmHg [64]. In the VASST study optimal sur-
vival occurred with a positive fluid balance of approxi-
mately three liters at twelve hours [31]. Recently, the
Protocolized Care for Early Septic Shock (ProCESS)
study was published which compared protocol-based
EGDT (Rivers’ protocol) and protocol-based standard
therapy with usual care [65]. It is noteworthy that the
amount of fluid given in the first 6 hours and from 7 to
72 hours was significantly less in the ProCESS EGDT
patients than in the Rivers’ EGDT patients (see Table 1).
As patients were resuscitated according to the same
protocol this would appear to be anomalous. However, it
should be noted that the mean CVP at 6 hours was
13.8 ± 4.4 mmHg in the Rivers’ EGDT group. Assuming
a normal distribution, 50% of patients in the Rivers’
EGDT would have achieved CVPs greater than the mean
value of 13.8 mmHg. Thus most patients in the Rivers’
EGDT study had CVPs outside the stated goal (>8 to 12
mmHg). Furthermore, the use of vasopressors in the first
six hours of EGDT was significantly greater in ProCESS
than in the Rivers’ study (see Table 1). We hypothesize
that targeting a lower mean CVP in the EGDT arm of
the ProCESS trial resulted in less fluid being given and
the earlier use of vasopressors. It is therefore possible
that the large amount of fluid administered in the Rivers’
study partly accounted for the mortality difference be-
tween the EGDT arms of the Rivers’ and ProCESS
studies.
Multiple RCT’s and cohort studies have demonstrated
that a conservative fluid strategy in patients undergoing
elective non-cardiac surgery is associated with signifi-
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itional liberal fluid strategy in which fluids are adminis-
tered to fill the non-existent ‘third space’ [5-7]. For
patients with traumatic injuries, high volume fluid resus-
citation as promoted by the early Advanced Trauma Life
Support (ATLS) strategy [8], has given way to a ‘damage
control’ resuscitation strategy [66]. This approach has
seen a fall in the volume of crystalloid delivered in the
emergency department and an associated fall in mortal-
ity. In a prospective analysis of 3,137 trauma patients
treated in the Emergency Department, fluid volumes of
1.5 liters or more were significantly associated with mor-
tality [67]. This observation is supported by a meta-
analysis which demonstrated in both RCTs and cohort
studies that a conservative fluid strategy was associated
with a lower mortality in trauma patients [68]. Similarly,
an aggressive fluid strategy in the resuscitation of pa-
tients with acute pancreatitis has been associated with
an increased risk of complications [69].
The results of multiple studies across diverse patient
populations have clearly demonstrated that aggressive
fluid resuscitation is associated with an increased risk of
complications and death. The only published study con-
ducted in adult patients that has demonstrated that early
aggressive fluid resuscitation improves outcome is the
EGDT study by Rivers et al. [2]. However, the results of
this study do not appear to be biologically plausible (im-
plausible effect size) [70], the elements of the protocol
were not based on evidence-based interventions [71],
the analysis of the results of study has come under scru-
tiny [72], and the results were not validated in a large
randomized controlled trial [65]. While hypovolemia will
result in decreased cardiac output (and blood pressure)
with inadequate organ perfusion leading to organ dys-
function, overzealous fluid resuscitation and hypervole-
mia induces a cascade of events that similarly results in
organ dysfunction. From an evolutionary point of view,
humans have evolved to deal with hypovolemia and not
hypervolemia. Hypervolemia is a recent (last 20 years) and
largely iatrogenic phenomenon. The argument is no lon-
ger ‘wet or dry’ but ‘just the right amount of fluid’ [73,74].
The dangers of a high CVP
Not only has the CVP failed as a useful measure for the
assessment of preload and fluid responsiveness [75], but
a CVP > 8 mmHg is independently associated with a
higher mortality and increased risk of AKI in patients
with sepsis and heart failure [13,31,76]. This suggests
that the CVP component of the six-hour resuscitation
bundle as widely promoted by the Surviving Sepsis Cam-
paign may lead to harm [28]. It is important to note that
a normal CVP is close to zero and not 8 to 12 mmHg as
the Surviving Sepsis Campaign might lead one to believe
[28]. The mean circulatory filling pressure (MCFP) isregarded as the driving pressure that determines venous
return and is considered synonymous with the effective
circulatory blood volume [77-81]. The MCFP is concep-
tualized as the pressure distending the vasculature when
the heart is stopped (zero flow) and the pressures in all
segments of the circulatory system have equalized
[78-80]. The MCFP in humans is normally in the range
of 8 to 10 mmHg [80]. According to Guyton, venous re-
turn is determined by the gradient between MCFP and
CVP [78]. An increase in the CVP or a fall in the MCFP
will reduce venous return, stroke volume and cardiac out-
put. Cecconi and colleagues investigated the relationship
between the changes in MCFP with the change in CVP
and stroke volume following a fluid challenge in postsurgi-
cal ICU patients [82]. In this study MCFP increased equally
in fluid responders and non-responders (3.1 ± 1.9 versus
3.1 ± 1.8 mmHg). However, the increase in the CVP was
greater in the non-responders than the responders. This
study emphasizes that a disproportionate increase in the
CVP will impede venous return and cardiac output [81].
In addition to influencing venous return, a high CVP
is transmitted backwards increasing venous pressure.
The increase in venous pressure has a profound effect
on microcirculatory flow and organ function. The kidney
is particularly affected by congestion and increased ven-
ous pressure, which leads to increased renal subcapsular
pressure and lowered renal blood flow and glomerular
filtration rate (GFR) [83]. Furthermore, increased renal
interstitial pressure may collapse intrarenal collecting
lymphatics which compromise lymph flow [84]. The det-
rimental effect of high venous pressure on renal function
was established by FR Winton in an elegant set of exper-
iments performed in 1930s [29]. This investigator at-
tached the kidneys of a dog to a heart-lung circulation
by means of cannulae inserted into the artery and veins
of the kidneys and then independently altered venous
and arterial pressure. Dr Winton demonstrated that in-
creasing venous pressure dramatically decreased urine
production. More recently, Legrand and colleagues in-
vestigated the association between hemodynamic vari-
ables and AKI in patients with sepsis [13]. In this study,
the CVP was the only hemodynamic variable associated
with the development of AKI; cardiac output, mixed
venous oxygen saturation (ScvO2) and mean arterial
pressure (MAP) were unable to predict the development
of AKI. These authors noted a linear relationship be-
tween increasing CVP and AKI; there was a trend for
higher CVP to be associated with worse renal outcome
for all levels of CVP above 4 mmHg, with a CVP of 15
mmHg being associated with an 80% risk of new or per-
sistent AKI, compared to approximately 30% at a CVP
of 6 mmHg. Van Biesen and colleagues demonstrated
that septic patients developing AKI had a higher positive
fluid balance, a higher CVP and worse oxygenation than
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out that these are observational data, and that it is likely
that other factors play a role in the pathophysiology of
AKI in sepsis. In patients with acute decompensated
heart failure, Mullens et al. demonstrated a near linear
relationship between increasing CVP and worsening
renal function [76]. In this study, worsening renal func-
tion occurred significantly less frequently in patients
with a CVP < 8 mmHg. Furthermore, similar to the find-
ings of Legrand and colleagues, the CVP was the only
hemodynamic parameter that predicted worsening renal
failure, with the cardiac index, systolic blood pressure
and pulmonary capillary wedge pressure being similar
between those patients who maintained renal function
as compared to those with worsening renal function. In
a subanalysis of the Evaluation Study of Congestive
Heart Failure and Pulmonary Artery Catheterization Ef-
fectiveness trial (ESCAPE), Nohria et al. demonstrated a
significant correlation between baseline renal function
and the CVP, there was, however no correlation between
baseline renal function and cardiac index, pulmonary ca-
pillary wedge pressure or systemic vascular resistance
[85]. These data suggest that a high CVP independently
increases the risk for ‘congestive kidney failure’. Most
clinicians fluid load patients with oliguria; this interven-
tion sets into motion a vicious cycle, with fluid loading
further increasing renal venous pressure with a further
decline in renal function and urine output [16].
In addition to increasing renal venous and interstitial
pressure, a high CVP will result in an increase in hepatic
and intestinal venous pressure causing hepatic and intes-
tinal congestion and impaired microcirculatory flow. In-
deed, in a study of 70 patients with sepsis, Vellinga and
colleagues demonstrated that the sublingual microvascu-
lar flow index (MFI) and percentage of perfused vessels
(PPV) was significantly lower with a patients with a high
CVP (>12 mmHg) than a low CVP: 1.44 ± 0.94 versus
1.89 ± 0.91, P = 0.006; and 88 ± 21 versus 95 ± 8%, P =
0.006) [30]. The cardiac index, MAP and perfusion pres-
sure (MAP-CVP) did not differ significantly between the
high and low CVP groups. In a multivariate logistic re-
gression analysis, the only significant predictor for an
abnormal MFI was a CVP > 12 mmHg. Because micro-
circulatory driving pressure is the difference between
post-arteriolar and venular pressure, a relatively mild in-
crease in CVP may considerably influence the capillary
perfusion pressure and microcirculatory flow [30]. As
the pressure drop in the vascular system occurs up-
stream at the level of small arterioles (resistance vessels),
the microcirculation is considered a low pressure com-
partment. Therefore, mean capillary pressure is much
closer to venous than to arterial pressure. Therefore, as
long as the MAP is within an organ’s autoregulatory
range, the CVP becomes the major determinant ofcapillary blood flow. This suggests that venous pressure
has a much greater effect on microcirculatory flow than
the MAP. The adverse consequences of volume overload
and a high CVP are summarized listed below
Consequences of volume overload
Pulmonary edema and increased extra-vascular lung water
Impaired oxygenation
Altered pulmonary and chest wall mechanics
















Consequences of a high central venous pressure
Decreased venous return and stroke volume
Acute kidney injury
Hepatic congestion
Decreased splanchnic microcirculatory flow
The dangers of a normal saline
Despite differences in composition between normal sa-
line (0.9% NaCl) and Lactated Ringer’s (LR), Normosol,
Isolyte and Plasmalyte solutions, they are frequently
considered physiologically equivalent. Whilst no body
fluid has an electrolyte composition similar to that of
normal saline (NS), this fluid is frequently referred to as
‘physiologic salt solution (PSS)’. However, 0.9% NaCl is
more correctly known as ‘Unphysiologic Salt Solution’.
Experimental and clinical data have clearly demonstrated
that these fluids are not physiologically equivalent. Only
LR, Normosol, Isolyte and Plasmalyte solutions are bal-
anced salt solutions. Due to the calcium content of LR
(and not Plasmalyte), it has been traditionally taught that
LR should not be infused in the same venous line as blood
(may activate clotting). However, this is not true [86].
Renal failure
The increased chloride load delivered to the macula densa
results in afferent arterial constriction [87]. In health
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renal cortisol tissue perfusion as compared to Plasmalyte
[88]. In a sequential cohort study Yunos and colleagues
demonstrated that a chloride liberal fluid (NS) was associ-
ated with a much higher incidence of renal failure than
critically patients resuscitated with a chloride restrictive
fluid (LR and Plasmalyte) [32].
Hyperchloremic metabolic acidosis and death
Numerous studies have demonstrated the development
of a hyperchloremic metabolic acidosis in human volun-
teers and patients resuscitated with NS [89-92]. The
additional loss (renal) of HCO3 in the setting of reduced
buffering capacity only adds to the acid–base burden
characteristic of hypoperfused states [90]. Furthermore,
resuscitation with NS may produce a ‘dilutional acidosis’.
In both experimental and clinical (pancreatitis) studies,
hyperchloremic acidosis has been demonstrated to in-
crease the release of inflammatory mediators [93,94]. In
a prospective cohort study, Boniatti et al. demonstrated
that hyperchloremia was an independent predictor of
death [95]. Similarly, in two large cohorts of patients
undergoing non-cardiac surgery, hyperchloremia was an
independently associated with increased morbidity and
mortality [33,34]. In these studies the risk of death in-
creased with increasing chloride levels. Using a large
multi-institutional database, Raghunathan et al. per-
formed propensity score matching in patients with se-
vere sepsis comparing resuscitation with balanced
solutions versus NS [35]. In this study, resuscitation with
a balanced solution was associated with a lower in-
hospital mortality (19.6% versus 22.8%; relative risk (RR)
0.86; 95% CI, 0.78 to 0.94).
Coagulopathy
Studies in surgical patients have demonstrated that as
compared to LR, volume replacement with NS results in
greater blood loss with a greater need for blood transfu-
sion [91]. The cause of the coagulopathy is unclear, and
is only partly explained by the difference in calcium be-
tween the two solutions.
Lactate as a metabolic fuel
It is not an accidental quirk of nature that the body pro-
duces lactate during stress states. The proportion of lac-
tate uptake by the myocardium and its use a metabolic
fuel increases during exercise, β-adrenergic stimulation
and shock [96-98]. During shock the heart undergoes a
major shift in substrate utilization such that it oxidizes
lactate for the majority of its energy needs [98]. Revelly
and coworkers demonstrated that an infusion of sodium
lactate increased cardiac performance in patients with
both cardiogenic and septic shock [99]. Similarly, during
increased demand on brain metabolism, lactate isincreasingly utilized as an energy substrate [100-102].
LR may therefore have additional advantages in shocked
patients with the lactate being oxidized and serving as a
source of energy [103,104].
Conclusions
A liberal fluid resuscitation strategy, a CVP > than 8
mmHg and the use of 0.9% NaCl as the predominant re-
suscitation fluid are all associated with an increased risk
of renal failure, respiratory failure, gastrointestinal dys-
function and death across a broad spectrum of clinical dis-
orders. These three treatment strategies probably act
synergistically to harm patients, forming the ‘Deadly Trio’.
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